We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Luminex Corporation Places 5,000th Instrument

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Luminex Corporation Places 5,000th Instrument"

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Read time:

Luminex Corporation has announced that it has recently delivered its 5,000th instrument to Beaumont Hospital in Royal Oak, Michigan. Beaumont Hospital, Royal Oak, will use the Luminex® 200™ instrument to perform the FDA-cleared Luminex xTAG™ Respiratory Viral Panel (RVP) to assist doctors in diagnosing respiratory infections.

"Multiplexing is, in many ways, the future of molecular diagnostics," said Dr. Domnita Crisan, medical director of the molecular pathology laboratory at Beaumont Hospital, Royal Oak. "The ability to run many tests at once provides us faster, more clinically relevant results. The Luminex instrument is an important multiplexing tool for us. It provides accurate results very quickly and efficiently, and is easy to use."

"Delivering our 5,000th instrument is an important milestone for Luminex as our proprietary xMAP® Technology, driven by the test menu expansion of our partners and the Luminex Assay Group, continues to gain momentum in the marketplace," said Patrick J. Balthrop, president and chief executive officer of Luminex Corporation.